Cited by 281Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsCoenzyme Q10 studies and effects

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Cytochrome c oxidase is decreased in Alzheimer’s disease platelets

Cardoso, Sandra Morais, Proença, M.Teresa, Santos, Sancha, Santana, Isabel, Oliveira, Catarina R·2004·Neurobiology of Aging

DOI 10.1016/s0197-4580(03)00033-2

Open this paper in CoChat — free account

Abstract

Cytochrome c oxidase (COX) activity reportedly is reduced in Alzheimer's disease (AD) brain and platelets. The reasons for the defect in either tissue are unknown, but its presence in a non-degenerating tissue suggests it is not simply a consequence of neurodegeneration. We now offer confirmation of the AD platelet COX defect. Compared to age-matched controls, in mitochondria isolated from AD platelets there was a 15% decrease in COX activity despite the fact that COX subunits were present at normal levels. Platelet ATP levels were diminished in AD (from 11.33 +/- 0.52 to 9.11 +/- 0.72 nmol/mg), while reactive oxygen species (ROS) were increased (from 97.03 +/- 25.9 to 338.3 +/- 100 K/mg). Platelet membrane fluidity, Vitamin E, and cholesterol content were similar between groups. We conclude that COX catalytic activity is indeed diminished in AD platelet mitochondria, does not result from altered membrane fluidity, and is associated with ROS overproduction and ATP under-production.

Integrity signals

Registry

Crossref · 10.1016/s0197-4580(03)00033-2

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,740
A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250
SEDMAK, J. J., & Grossberg, S. E. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90428-6 · Cited by 3,019
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen
Boveris, A., & Chance, B. (1973) · Biochemical Journal · doi:10.1042/bj1340707 · Cited by 2,626
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Fluidity parameters of lipid regions determined by fluorescence polarization
Shinitzky, M., & Barenholz, Y. (1978) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(78)90010-2 · Cited by 1,885
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.
Bass, D., Parce, J. W., DeChatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,811
[45] Cytochrome oxidase from beef heart mitochondria
Wharton, D. C., & Tzagoloff, A. (1967) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(67)10048-7 · Cited by 1,264
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Lipid peroxidation damage to cell components.
Tappel, A. L. (1973) · PubMed · Cited by 902

Show all 38 references

Research works printed but not linked: 1

Ragan CI, Wilson MT, Darley-Usmar VM, Lowe PN. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorylation. In: Mitochondria, a practical approach. London: IRL Press; 1987. p. 79–112.

Sorted by citations

Items 101–200 of 280

Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Arnold, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_13 · Cited by 77
Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease
Leuner, K., Pantel, J., Frey, C., Schindowski, K., Schulz, K. L., Wegat, T., Maurer, K., Eckert, A., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_27 · Cited by 74
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 75
Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta
Teo, E., Ravi, S., Barardo, D., Kim, H.-S., Fong, S., Cazenave-Gassiot, A., Tan, T. Y., Ching, J., Kovalik, J.-P., Wenk, M. R., et al. (2019) · eLife · doi:10.7554/elife.50069 · Cited by 72
Mitochondrial Dysfunction and Alzheimers Disease
Chen, X., Stern, D. M., & Yan, S. D. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025215 · Cited by 71
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
Hroudová, J., Singh, N., Fišar, Z., & Ghosh, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.084 · Cited by 71
Clinical Features and Pathogenesis of Alzheimer’s Disease: Involvement of Mitochondria and Mitochondrial DNA
Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., & Siciliano, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_4 · Cited by 69
Huperzine a attenuates mitochondrial dysfunction in β‐amyloid‐treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism
Gao, X., & Tang, X. C. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20791 · Cited by 67
Mitophagy and the Brain
Swerdlow, N., & Wilkins, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249661 · Cited by 66
Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
Korábečný, J., Nepovimová, E., Cikánková, T., Špilovská, K., Vašková, L., Mezeiová, E., Kuča, K., & Hroudová, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.034 · Cited by 64
Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 64
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Samanta, S., Akhter, F., Roy, A., Chen, D., Turner, B., Wang, Y., Clemente, N., Wang, C., Swerdlow, R. H., Battaile, K. P., et al. (2023) · Brain · doi:10.1093/brain/awad432 · Cited by 62
Amyloid-β-Induced Mitochondrial Dysfunction Impairs the Autophagic Lysosomal Pathway in a Tubulin Dependent Pathway
Silva, D. F., Esteves, A. R., Arduíno, D. M., Oliveira, C. R., & Cardoso, S. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110423 · Cited by 61
Self-citation
Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: A pilot study
Straface, E., Matarrese, P., Gambardella, L., Vona, R., Sgadari, A., Silveri, M. C., & Malorni, W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.094 · Cited by 59
Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease
Xu, X., Yang, M.-S., Zhang, B., Niu, F., Dong, J., & Liu, B. (2020) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2020.10.001 · Cited by 59
Metabolic Disturbances in Diseases with Neurological Involvement
Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500238 · Cited by 55
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 56
Mitochondria Are Related to Synaptic Pathology in Alzheimer′s Disease
Balogiannis, S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/305395 · Cited by 58
Mitochondria and Alzheimer’s disease: amyloid-β peptide uptake and degradation by the presequence protease, hPreP
Alikhani, N., Ankarcrona, M., & Glaser, E. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9244-4 · Cited by 55
Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex
Wang, Y., & Brinton, R. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00232 · Cited by 52
Genetic association of the cytochrome c oxidase-related genes with Alzheimer’s disease in Han Chinese
Bi, R., Zhang, W., Zhang, D., Xu, M., Fan, Y., Hu, Q.-X., Jiang, H., Tan, L., Li, T., Fang, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0144-3 · Cited by 54
Mitochondrial function and Aβ in Alzheimer's disease postmortem brain
Troutwine, B. R., Strope, T. A., Franczak, E., Lysaker, C. R., Hamid, L., Mansel, C., Stopperan, J. A., Gouvion, C. M., Haeri, M., Swerdlow, R. H., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105781 · Cited by 51
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 50
Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders
Espinosa‐Parrilla, Y., González-Billault, C. E., Eduardo Fuentes, Q., Palomo, I. F., & Alarcón, M. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00151 · Cited by 50
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Líšková, A., Samec, M., Koklesová, L., Kúdela, E., Kubatka, P., & Golubnitschaja, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042007 · Cited by 48
Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target
Villarejo, L. G., Bachmann, L., Marks, D., Brachthäuser, M., Geidies, A., & Müller, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094656 · Cited by 48
Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain
Zulfiqar, S., Garg, P., & Nieweg, K. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0140 · Cited by 46
Blood-based bioenergetics: An emerging translational and clinical tool
Braganza, A., Annarapu, G. K., & Shiva, S. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100835 · Cited by 47
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's
Mosconi, L., Glodzik, L., Mistur, R., McHugh, P., Rich, K. E., Javier, E., Williams, S., Pirraglia, E., De Santi, S., Mehta, P. D., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.011 · Cited by 46
Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies
Salehpour, F., Khademi, M., & Hamblin, M. R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210029 · Cited by 48
Perspectives on the Molecular Mediators of Oxidative Stress and Antioxidant Strategies in the Context of Neuroprotection and Neurolongevity: An Extensive Review
Shohag, S., Akhter, S., Islam, M. S., Sarker, T., Sifat, M. K., Rahman, M. M., Islam, M. R., & Sharma, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7743705 · Cited by 49
Strategic Role for Mitochondria in Alzheimer's Disease and Cancer
Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 45
Genetic basis of Alzheimer's dementia: role of mtDNA mutations
Grazina, M. M., Pratas, J., Silva, F., Oliveira, S. A., Santana, I. J., & Oliveira, C. R. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00225.x · Cited by 47
Self-citation
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303007 · Cited by 45
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44
Self-citation
Data mining of high density genomic variant data for prediction of Alzheimer's disease risk
Briones, N., & Dinu, V. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-7 · Cited by 43
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
Martínez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 46
Enhanced defense against mitochondrial hydrogen peroxide attenuates age-associated cognition decline
Chen, L., Na, R., & Ran, Q. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.007 · Cited by 39
Mitochondrial dysfunction in neocortex and hippocampus of olfactory bulbectomized mice, a model of Alzheimer’s disease
Avetisyan, A. V., Samokhin, A. N., Alexandrova, I., Zinovkin, R. A., Simonyan, R. A., & Бобкова, Н. В. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916060080 · Cited by 38
Interactions between amyloid, amyloid precursor protein, and mitochondria
Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37
Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion
Wilkins, H., Troutwine, B., Menta, B. W., Manley, S., Strope, T., Lysaker, C., & Swerdlow, R. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215280 · Cited by 38
Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations
Keil, U., Hauptmann, S., Bonert, A., Scherping, I., Eckert, A., & Müller, W. E. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9206 · Cited by 36
Amyloid-β-Peptide Reduces the Expression Level of Mitochondrial Cytochrome Oxidase Subunits
Hong, W. K., Han, E. H., Kim, D. G., Ahn, J. Y., Park, J. S., & Han, B. G. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9336-7 · Cited by 36
Problems Associated with Biological Markers of Alzheimer’s Disease
Frey, H. J., Mattila, K. M., Korolainen, M. A., & Pirttilä, T. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8827-7 · Cited by 37
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
Quantitative Proteomic Analysis of Mitochondria in Aging PS-1 Transgenic Mice
Fu, Y.-J., Xiong, S., Lovell, M. A., & Lynn, B. C. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9359-5 · Cited by 35
Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease
Mangrulkar, S. V., Wankhede, N. L., Kale, M. B., Upaganlawar, A. B., Taksande, B. G., Umekar, M. J., Anwer, M. K., Dailah, H. G., Mohan, S., & Behl, T. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00647-2 · Cited by 35
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
Atlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 33
The multifaceted role of quercetin derived from its mitochondrial mechanism
Carrillo-Garmendia, A., Pérez, L. A. M., & Regalado‐González, C. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04833-w · Cited by 36
Mitochondrial DNA Manipulations Affect Tau Oligomerization
Weidling, I. W., Wilkins, H., Koppel, S. J., Hutfles, L. J., Wang, X., Kalani, A., Menta, B. W., Ryan, B. J., Ortiz, J. P., Gamblin, T. C., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200286 · Cited by 31
Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease
Donner, L., Feige, T., Freiburg, C., Toska, L. M., Reichert, A. S., Chatterjee, M., & Elvers, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179633 · Cited by 32
Intermittent hypoxia conditioning protects mitochondrial cytochrome c oxidase of rat cerebellum from ethanol withdrawal stress
Ju, X., Mallet, R. T., Downey, H. F., Metzger, D. B., & Jung, M. E. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01428.2011 · Cited by 31
Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
S-allyl-L-cysteine and isoliquiritigenin improve mitochondrial function in cellular models of oxidative and nitrosative stress.
Denzer, I., Münch, G., Pischetsrieder, M., & Friedland, K. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.08.052 · Cited by 31
Alzheimer's Disease: The Quest to Understand Complexity
Marques, S., Oliveira, C. R., Outeiro, T. F., & Pereira, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100303 · Cited by 30
Self-citation
Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
Michikawa, M. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00681.x · Cited by 29
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis
Iñarrea, P., Alarcia, R., Álava, M. A., Capablo, J. L., Casanova, A., Íñiguez, C., Iturralde, M., Larrodé, P., Martín, J., Mostacero, E., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8481-z · Cited by 29
Detection of Membrane Fluidity in Submitochondrial Particles of Platelets and Erythrocyte Membranes from Mexican Patients with Alzheimer Disease by Intramolecular Excimer Formation of 1,3 Dipyrenylpropane
Ortiz, G. G., Pacheco-Moisés, F. P., Hafidi, M. E., Jiménez-Delgado, A., Macías-Islas, M. Á., Rosales‐Corral, S., de la Rosa, A. C., Sánchez-González, V., Arias‐Merino, E. D., & Velázquez-Brizuela, I. E. (2008) · Disease Markers · doi:10.1155/2008/642120 · Cited by 28
The organellar peptidasome, PreP: A journey from Arabidopsis to Alzheimer's disease
Glaser, E. G., & Alikhani, N. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.12.016 · Cited by 28
RETRACTED: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
Rao, S. S., Lago, L., de Vega, R. G., Bray, L., Hare, D. J., Clases, D., Doble, P., & Adlard, P. A. (2019) · Metallomics · doi:10.1039/c9mt00267g · Cited by 27
Retracted
Mitochondrial dysfunction and Alzheimer's disease: New developments
Mancuso, M., Siciliano, G., Filosto, M., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9203 · Cited by 28
Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
Esteras, N., Alquézar, C., de la Encarnación, A., Villarejo‐Galende, A., Bermejo‐Pareja, F., & Martín‐Requero, Á. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt219 · Cited by 26
Altered Subcellular Distribution of the Alzheimer's Amyloid Precursor Protein Under Stress Conditions
Domingues, S. C., Henriques, A. G., Wu, W., Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.085 · Cited by 26
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer’s Disease
Kashif, M., Sivaprakasam, P., Vijendra, P. D., Waseem, M., & Pandurangan, A. K. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128264355231121064704 · Cited by 26
Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer’s disease
de Morais, F. M., Ribeiro, A. M., Moreira, F. A., & Silva, P. V. G. (2020) · Acta Neuropsychiatrica · doi:10.1017/neu.2020.43 · Cited by 27
Relationship between Cognitive Dysfunction and Age-Related Variability in Oxidative Markers in Isolated Mitochondria of Alzheimer’s Disease Transgenic Mouse Brains
Yoshida, N., Kato, Y., Takatsu, H., & Fukui, K. (2022) · Biomedicines · doi:10.3390/biomedicines10020281 · Cited by 23
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
Flannagan, K., Stopperan, J. A., Hauger, B. M., Troutwine, B., Lysaker, C. R., Strope, T. A., Csikós, V., Gilmore, C. A., Swerdlow, N., Draper, J. M., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1201015 · Cited by 24
Statin-Induced Changes in Mitochondrial Respiration in Blood Platelets in Rats and Human With Dyslipidemia
Vevera, J., Fišar, Z., Nekovářová, T., Vrablı́k, M., Zlatohlávek, L., Hroudová, J., Singh, N., Raboch, J., & Valeš, K. (2016) · Physiological Research · doi:10.33549/physiolres.933264 · Cited by 24
Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer’s Disease
Correia, S. C., Machado, N. J., Alves, M. G., Oliveira, P. F., & Moreira, P. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010461 · Cited by 25
Interactions between BIM Protein and Beta-Amyloid May Reveal a Crucial Missing Link between Alzheimer’s Disease and Neuronal Cell Death
Malishev, R., Nandi, S., Śmiłowicz, D., Bakavayev, S., Engel, S., Bujanover, N., Gazit, R., Metzler‐Nolte, N., & Jelinek, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00177 · Cited by 21
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease
Moreira, P. I., Zhu, X., Lee, H., Honda, K., Smith, M. A., & Perry, G. L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.024 · Cited by 22
Ethanol withdrawal posttranslationally decreases the activity of cytochrome c oxidase in an estrogen reversible manner
Jung, M. E., Agarwal, R., & Simpkins, J. W. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.065 · Cited by 22
DNA repair deficiencies and neurodegeneration
Ropert, B., Gallrein, C., & Schumacher, B. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103679 · Cited by 21
Interference With Complex IV as a Model of Age-Related Decline in Synaptic Connectivity
Kriebel, M., Ebel, J., Battke, F., Griesbach, S., & Volkmer, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00043 · Cited by 21
Replication study of plasma proteins relating to Alzheimer's pathology
Shi, L., Winchester, L. M., Westwood, S., Baird, A. L., Anand, S. N., Buckley, N. J., Hye, A., Ashton, N. J., Bos, I., Vos, S. J. B., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12322 · Cited by 20
Exploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease
Chadha, S., Behl, T., Sehgal, A., Kumar, A., & BUNGAU, S. G. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.008 · Cited by 20
Role of Amyloid-β–Metal Interactions In Alzheimer‘s Disease
Duce, J. A., Bush, A. I., & Adlard, P. A. (2011) · Future Neurology · doi:10.2217/fnl.11.43 · Cited by 20
Analyzing Olfactory Neuron Precursors Non-Invasively Isolated through NADH FLIM as a Potential Tool to Study Oxidative Stress in Alzheimer’s Disease
Gomez‐Virgilio, L., Luarte, A., Ponce, D. P., Bruna, B., & Behrens, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126311 · Cited by 18
Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease
Omori, C., Motodate, R., Shiraki, Y., Chiba, K., Sobu, Y., Kimura, A., Nakaya, T., Kondo, H., Kurumiya, S., Tanaka, T., et al. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1199114 · Cited by 20
The Key Role of Oxidative Stress in Alzheimer's Disease
Moreira, P. I., Nunomura, A., Honda, K., Aliev, G. M., Casadesús, G., Zhu, X., Smith, M. A., & Perry, G. L. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50153-8 · Cited by 18
Identification of genes differentially expressed in SH‐SY5Y neuroblastoma cells exposed to the prion peptide 106–126
Martínez, T., & Pascual, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05646.x · Cited by 18
Intense long‐term training impairs brain health compared with moderate exercise: Experimental evidence and mechanisms
Sangüesa, G., Batlle, M., Muñoz‐Moreno, E., Sòria, G., Alcarraz, A., Rubies, C., Sitjà‐Roqueta, L., Solana, E., Martínez‐Heras, E., Meza‐Ramos, A., et al. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14912 · Cited by 16
Intrinsic aerobic capacity modulates Alzheimer’s disease pathological hallmarks, brain mitochondrial function and proteome during aging
Kugler, B. A., Lysaker, C. R., Franczak, E., Hauger, B. M., Csikós, V., Stopperan, J. A., Allen, J., Stanford, J. A., Koch, L. G., Britton, S. L., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01248-3 · Cited by 17
Biochemical Studies of Poly-T Variants in the Alzheimer's Disease Associated TOMM40 Gene
Hedskog, L., Brohede, J., Wiehager, B., Pinho, C. M., Revathikumar, P., Lilius, L., Glaser, E. G., Graff, C., Karlström, H., & Ankarcrona, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120580 · Cited by 17
Effects of Edaravone on Amyloid-β Precursor Protein Processing in SY5Y-APP695 Cells
Shen, Y., Wang, Y., Yu, G., Liu, C., Zhang, Z., & Zhang, L. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9370-3 · Cited by 17
Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease
Bobba, A., Amadoro, G., Petragallo, V. A., Calissano, P., & Atlante, A. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.04.001 · Cited by 17
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 16
Detection of Alzheimer's disease by Raman spectra of rat's platelet with a simple feature selection
Park, A., Baek, S., Shen, A., & Hu, J. (2012) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2012.11.011 · Cited by 16
Silica Nanoparticles for the Oriented Encapsulation of Membrane Proteins into Artificial Bilayer Lipid Membranes
Schadauer, F., Geiss, A. F., Srajer, J., Siebenhofer, B., Frank, P., Reiner‐Rozman, C., Ludwig, B., Richter, O. H., Nowak, C., & Naumann, R. L. C. (2015) · Langmuir · doi:10.1021/la504417j · Cited by 16
Bilobalide Protects Mitochondrial Function in Ovariectomized Rats by Up-regulation of mRNA and Protein Expression of Cytochrome c Oxidase Subunit I
Shi, C., Zou, J., Li, G., Zhenying, G., Yao, Z., & Xu, J. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9388-z · Cited by 15
A disease-modifying treatment for Alzheimer’s disease: focus on the trans-sulfuration pathway
Berry, T. M., Hamza, E. A., & Moustafa, A. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0076 · Cited by 14
Small‐scale immunopurification of cytochrome c oxidase for a high‐throughput multiplexing analysis of enzyme activity and amount
Murray, J. M., Schilling, B., Row, R. H., Yoo, C. B., Gibson, B. W., Marusich, M. F., & Capaldi, R. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060223 · Cited by 14
A mutation in the NADH-dehydrogenase subunit 2 suppresses fibroblast aging
Schauer, M., Kottek, T., Schönherr, M., Bhattacharya, A., Ibrahim, S. M., Hirose, M., Köhling, R., Fuellen, G., Schmitz, U., & Kunz, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3298 · Cited by 13
Platelet Mitochondrial Complex I and I+III Activities Do Not Correlate with Cerebral Mitochondrial Oxidative Metabolism
Powers, W. J., Haas, R., Le, T., Videen, T. O., Markham, J., & Perlmutter, J. S. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.179 · Cited by 13
Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer’s disease
Ball, B. K., Park, J. H., Bergendorf, A. M., Proctor, E. A., & Brubaker, D. K. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00539-5 · Cited by 12
Quantitative Cytochrome Oxidase Histochemistry: Applications in Human Alzheimer's Disease and Animal Models
Valla, J., Schneider, L. E., Small, A. M., & Gonzalez-Lima, F. (2007) · Journal of Histotechnology · doi:10.1179/his.2007.30.4.235 · Cited by 11
Effects of Al Exposure on Mitochondrial Dynamics in Rat Hippocampus
Nie, J., Lv, S., Fu, X., & Niu, Q. L. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00045-7 · Cited by 13
Mapping cellular stress and lipid dysregulation in Alzheimer-related progressive neurodegeneration using label-free Raman microscopy
Haessler, A., Candlish, M., Hefendehl, J. K., Jung, N., & Windbergs, M. (2024) · Communications Biology · doi:10.1038/s42003-024-07182-6 · Cited by 10
The role of mitochondrial remodeling in neurodegenerative diseases
Guan, D., Liang, C., Zheng, D., Liu, S., Luo, J., Cai, Z., Zhang, H., & Chen, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2024.105927 · Cited by 11
Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review
Mukherjee, A. G., Mishra, S., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Wanjari, U. R., Stany, B. K., Vellingiri, B., Madhyastha, H., Deepankumar, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102726 · Cited by 11

Authors: Cardoso, S. M., Proença, M. T., Santos, S., Santana, I., & Oliveira, C. R.
Affiliations: University of Coimbra (PT)
Unidade Local de Saúde de Coimbra (PT)
Corresponding author: Oliveira, Catarina R
ORCID: Cardoso, Sandra Morais
Santana, Isabel
Oliveira, Catarina R
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 2004-01
Volume: 25
Issue: 1
Pages: 105-110
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/s0197-4580(03)00033-2
OpenAlex: W2072453593
Cited by: 281
References: 38
Citations by year: 2026: 9 · 2025: 11 · 2024: 9 · 2023: 15 · 2022: 13 · 2021: 16 · 2020: 14 · 2019: 16 · 2018: 7 · 2017: 9 · 2016: 14 · 2015: 10 · 2014: 13 · 2013: 22 · 2012: 17
FWCI: 3.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Keywords: cytochrome c oxidase, Alzheimer's disease, platelets, mitochondrial dysfunction, ATP production, reactive oxygen species, platelet mitochondria, platelet membrane fluidity, vitamin E, cholesterol
MeSH terms: Adenine Nucleotides, Adenosine Triphosphate, Aged, Alzheimer Disease, Blood Platelets, Cholesterol, Chromatography, High Pressure Liquid, Citrate (si)-Synthase, Electron Transport Complex IV, Free Radicals, Humans, Middle Aged, Mitochondria, NADP, Succinate Cytochrome c Oxidoreductase, Vitamin E, Electrophoresis, Gel, Two-Dimensional, Case-Control Studies, Age of Onset, Electron Transport Complex I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytochrome c oxidase is decreased in Alzheimer’s disease platelets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks